Lund, Søren S.
Boehringer Ingelheim (Germany)
6 papers on CoChat
Most cited papers
- Verified
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
Hemmingsen, B., Lund, S. S., Gluud, C., Vaag, A., Almdal, T., Hemmingsen, C., & Wetterslev, J. (2011) · BMJ
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 386
- Verified
Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin
Cherney, D. Z. I., Cooper, M. E., Tikkanen, I., Pfarr, E., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Lund, S. S. (2018) · Kidney International
Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies
Cited by 243
- Verified
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus
Neeland, I. J., McGuire, D. K., Chilton, R., Crowe, S., Lund, S. S., Woerle, H. J., Broedl, U. C., & Johansen, O. E. (2016) · Diabetes and Vascular Disease Research
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 168
- Verified
The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus
Jordan, J., Tank, J., Heusser, K., Heise, T., Wanner, C., Heer, M., Macha, S., Mattheus, M., Lund, S. S., Woerle, H. J., et al. (2017) · Journal of the American Society of Hypertension
Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies
Cited by 102
- Verified
Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?
Vaag, A., & Lund, S. S. (2007) · Applied Physiology, Nutrition, and Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 89
- Verified
Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
Lund, S. S., Tarnow, L., Frandsen, M., Nielsen, B. B., Hansen, B. V., Pedersen, O., Parving, H.-H., & Vaag, A. A. (2009) · BMJ
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 41
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free